MGC Pharmaceuticals Limited (MXC)’in fiyatı nedir?

MGC Pharmaceuticals Limited (MXC)’in fiyatı $0.27239819’dir

MGC Pharmaceuticals Limited (MXC)’in piyasa değeri nedir?

MGC Pharmaceuticals Limited (MXC)’in piyasa değeri $330.42K’dir.

MGC Pharmaceuticals Limited (MXC) HBK

MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established in West Perth in 2014, focuses on the worldwide development and distribution of plant-derived medicines. Its product portfolio encompasses both medicinal cannabis solutions and other botanical therapeutics. The company's key investigational treatments include CimetrA, currently in Phase III clinical trials for the symptomatic relief of early-stage COVID-19; CannEpil, a cannabis-based therapy undergoing Phase IIb studies for drug-resistant epilepsy; and CogniCann, which is in Phase II clinical development for alleviating dementia symptoms. Beyond these core candidates, MGC Pharmaceuticals also supplies the ArtemiC range, various other cannabinoid-infused products, and non-pharmaceutical items. Additionally, the company provides expert consulting services, particularly in clinical research. The company was previously named Erin Resources Limited before adopting its current identity, MGC Pharmaceuticals Limited, in December 2015.

Yıl	EPS	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

EPS

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	EPS	EPS Farkı	Ülke
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN

Şirket

EPS

EPS Farkı

Ülke